Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Paull

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Molecular Pharmacology|March 14, 1998
Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activityL M Shi, T G Myers, Y Fan, et al.
Journal of Chemical Information and Computer Sciences|April 16, 1998
Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analoguesL M Shi, Y Fan, T G Myers, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Mechanism of triamterene transfer across the human placentaM S Ching, M A Czuba, G W Mihaly, et al.
Journal of Chemical Information and Computer Sciences|April 13, 2000
Mining and visualizing large anticancer drug discovery databasesL M Shi, Y Fan, J K Lee, et al.
Journal of Experimental Therapeutics & Oncology|May 1, 1996
Studies on the mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) in mammalian lymphoblastsJ J Barchi, D A Cooney, G S Ahluwalia, et al.
Australian and New Zealand Journal of Medicine|December 1, 1977
The effects of enteric coating of aspirin tablets on occult gastrointestinal blood lossG B Howe, G D Champion, A B Corrigan, et al.
Cancer Research|April 15, 1989
Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumorsJ Plowman, S D Harrison, D J Dykes, et al.
Statistics in Medicine|March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of actionA D Koutsoukos, L V Rubinstein, D Faraggi, et al.
Investigational New Drugs|September 1, 1988
Preclinical antitumor activity of batracylin (NSC 320846)J Plowman, K D Paull, G Atassi, et al.
Journal of the National Cancer Institute|July 4, 1990
Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell linesL V Rubinstein, R H Shoemaker, K D Paull, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Molecular Pharmacology|March 14, 1998
Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activityL M Shi, T G Myers, Y Fan, et al.
Journal of Chemical Information and Computer Sciences|April 16, 1998
Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analoguesL M Shi, Y Fan, T G Myers, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Mechanism of triamterene transfer across the human placentaM S Ching, M A Czuba, G W Mihaly, et al.
Journal of Chemical Information and Computer Sciences|April 13, 2000
Mining and visualizing large anticancer drug discovery databasesL M Shi, Y Fan, J K Lee, et al.
Journal of Experimental Therapeutics & Oncology|May 1, 1996
Studies on the mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) in mammalian lymphoblastsJ J Barchi, D A Cooney, G S Ahluwalia, et al.
Australian and New Zealand Journal of Medicine|December 1, 1977
The effects of enteric coating of aspirin tablets on occult gastrointestinal blood lossG B Howe, G D Champion, A B Corrigan, et al.
Cancer Research|April 15, 1989
Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumorsJ Plowman, S D Harrison, D J Dykes, et al.
Statistics in Medicine|March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of actionA D Koutsoukos, L V Rubinstein, D Faraggi, et al.
Investigational New Drugs|September 1, 1988
Preclinical antitumor activity of batracylin (NSC 320846)J Plowman, K D Paull, G Atassi, et al.
Journal of the National Cancer Institute|July 4, 1990
Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell linesL V Rubinstein, R H Shoemaker, K D Paull, et al.
Pageof 12